Back to Results

BioLargo Inc (BLGO)

BioLargo Inc. is a common stock listing on OTC Markets under the symbol BLGO. The company develops and commercializes platform technologies in the United States with a focus on environmental and related applications. Its work addresses PFAS water contamination, water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and environmental remediation. BioLargo also provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. The company is based in Westminster, California.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-BLGO
$0.097
-12.1% Downside
Fair
$0.32
190.9% Upside
Bargain
Weak
—
—
—
0.0%
August 18, 2026
-2.9x
21.2x
6.7x
35.193 M
37.36 M
14.6%
85.6%
-30.0
—
73.3%
Valuation • Fair Value

BioLargo Inc (OTC-BLGO) Fair Value by Valuation Model

Compare the primary fair value estimate for BioLargo Inc (OTC-BLGO) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.097

Estimated downside of 12.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.090

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.10

Comparable-company valuation reference.

Analyst Price Target

$0.32

Analysts imply upside of 190.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for BioLargo Inc (OTC-BLGO) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for BioLargo Inc (OTC-BLGO)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

5.611 M

Current operating scale indicator.

Revenue Forecast

5.276 M

Forward revenue estimate.

EBITDA

-16.034 M

Current operating profitability reference.

EBITDA Forecast

-11.264 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review BioLargo Inc (OTC-BLGO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for BioLargo Inc (OTC-BLGO)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

0

Weak quality score that deserves closer review.

Beneish M-Score

-6.22

No elevated caution signal from this screen.

Altman Z-Score

-30.0

Lower score that deserves closer risk review.

FCF / Net Income

73.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for BioLargo Inc (OTC-BLGO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for BioLargo Inc (OTC-BLGO)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 18, 2026

Days to Earnings

28

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for BioLargo Inc (OTC-BLGO), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

BioLargo Inc (OTC-BLGO) Stock Forecast & Technical Outlook

Review BioLargo Inc (OTC-BLGO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for BioLargo Inc (OTC-BLGO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for BioLargo Inc (OTC-BLGO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for BioLargo Inc (OTC-BLGO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for BioLargo Inc (OTC-BLGO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for BioLargo Inc (OTC-BLGO) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for BioLargo Inc (OTC-BLGO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, BioLargo Inc (OTC-BLGO) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

BioLargo Inc (OTC-BLGO) Stock FAQ

Quick answers about BioLargo Inc (OTC-BLGO) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.097
Estimated downside 12.1%
Valuation Rating
Overvalued
Estimated downside of 12.1%
Analyst Target
$0.32
Implied upside 190.9%
Financial Health
Weak
Current financial-health read

The current fair value estimate for BioLargo Inc (OTC-BLGO) is $0.097. This implies an estimated downside of 12.1% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 12.1% versus the current market price.

The available analyst price target for BioLargo Inc (OTC-BLGO) is $0.32. The analyst target implies estimated upside of 190.9%.

The current financial health read for BioLargo Inc (OTC-BLGO) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for BioLargo Inc (OTC-BLGO) is August 18, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for BioLargo Inc (OTC-BLGO) is -2.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for BioLargo Inc is 35.193 M.

The current enterprise value listed for BioLargo Inc is 37.36 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for BioLargo Inc is OTC-BLGO, and the stock is listed on OTC Markets.

BioLargo Inc (OTC-BLGO) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for BioLargo Inc is 14.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for BioLargo Inc is 85.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Chemicals Stocks on OTC Markets View more

Air Liquide SA ADR (AIQUY) Air Liquide SA ADR (AIQUY)
Shin-Etsu Chemical Co Ltd ADR (SHECY) Shin-Etsu Chemical Co Ltd ADR (SHECY)
BASF SE ADR (BASFY) BASF SE ADR (BASFY)
BASF SE NA O.N. (BFFAF) BASF SE NA O.N. (BFFAF)
Givaudan SA ADR (GVDNY) Givaudan SA ADR (GVDNY)
Sika AG ADR (SXYAY) Sika AG ADR (SXYAY)
Novozymes AS (NVZMF) Novozymes AS (NVZMF)
Novozymes AS DRC (NVZMY) Novozymes AS DRC (NVZMY)
Resonac Holdings Corp DRC (SHWDY) Resonac Holdings Corp DRC (SHWDY)
Asahi Kaisei Corp (AHKSY) Asahi Kaisei Corp (AHKSY)
Covestro ADR (COVTY) Covestro ADR (COVTY)
Symrise Ag PK (SYIEY) Symrise Ag PK (SYIEY)
Ganfeng Lithium Co Ltd (GNENF) Ganfeng Lithium Co Ltd (GNENF)
Nitto Denko Corp (NDEKY) Nitto Denko Corp (NDEKY)
Yara International ASA (YARIY) Yara International ASA (YARIY)
Akzo Nobel NV ADR (AKZOY) Akzo Nobel NV ADR (AKZOY)
Chandra Asri Petrochemical Tbk PT ADR (PTCAY) Chandra Asri Petrochemical Tbk PT ADR (PTCAY)
Toray Industries Inc ADR (TRYIY) Toray Industries Inc ADR (TRYIY)
Mitsubishi Chemical Holdings Corp ADR (MTLHY) Mitsubishi Chemical Holdings Corp ADR (MTLHY)
Orica Ltd ADR (OCLDY) Orica Ltd ADR (OCLDY)
Nissan Chemical Industries Ltd ADR (NNCHY) Nissan Chemical Industries Ltd ADR (NNCHY)
Croda International PLC ADR (COIHY) Croda International PLC ADR (COIHY)
Sumitomo Chemical Co Ltd ADR (SOMMY) Sumitomo Chemical Co Ltd ADR (SOMMY)
Fuchs Se ADR (FUPBY) Fuchs Se ADR (FUPBY)